Website stats for Discoverx - discoverx.com
Cells & Cell LinesAssay Ready KitsMembrane PrepsProteins & Enzymes Target ClassA-Z List of Targets Special OffersSubmit an Order TechnologiesDocument Library CRO CertificationDiscovery ServicesIntegrated Discovery
discoverx.com was registered 2 decades 5 years ago. It has a alexa rank of #1,392,212 in the world. It is a domain having .com extension. It is estimated worth of $ 960.00 and have a daily income of around $ 4.00. As no active threats were reported recently, discoverx.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 630 |
| Daily Pageviews: | 1,260 |
Estimated Valuation
| Income Per Day: | $ 4.00 |
| Estimated Worth: | $ 960.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 1,392,212 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
52.42.252.147
Hosted Country:
US
Location Latitude:
45.5234Location Longitude:
-122.676Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | No Data |
| Referral Traffic: | No Data |
| Search Traffic: | No Data |
| Social Traffic: | No Data |
| Mail Traffic: | No Data |
| Display Traffic: | No Data |
Search Engine Results For discoverx.com
Eurofins - Drug Target Review
DiscoverX Corporation is the leading supplier of innovative cell-based assays and services for drug discovery and development.
DiscoveRX Company Profile - Office Locations, Competitors ...
DiscoveRx® is an innovative company that develops, manufactures, and commercializes reagents, complete cell-based assay kits, profiling and screening ...
DiscoverX Contact Information | Biocompare.com
DiscoveRx Corporation 42501 Albrae St. Fremont, California 94538. United States. Phone: (510) 979-1415.
Eurofins DiscoverX Grants Bioassay Certification to VelaLabs of ...
Feb 24, 2020 ... PRNewswire/ -- Eurofins DiscoverX, the products company of Eurofins Discovery, today announced their partnership with VelaLabs of Vienna, ...
Enzyme fragment complementation: a flexible high throughput ...
Affiliation. 1 DiscoveRx Corporation, Fremont, CA 94538, USA. reglen@ discoverx.com. PMID: 15090161; DOI: 10.1089/154065802761001356 ...
A generic, homogenous method for measuring kinase and inhibitor ...
Affiliation. 1 DiscoveRx Corporation, Fremont, California 94538, USA. ncharter@ discoverx.com. PMID: 16751335; DOI: 10.1177/1087057106286829 ...
Eurofins Discoverx PathHunter Detection Kit, 75 ... - Fisher...
Shop Eurofins Discoverx PathHunter Detection Kit, 75 (10 plates), 1000/4000 dp (96-well/384-well). (93-0001) at Fishersci.com.
HitHunter IP3 assay for GPCR screening on a Plate Reader | BMG ...
DiscoverX has developed a homogeneous assay based on fluorescence polarization (FP), to measure IP3 levels generated by GPCR activation. This application ...
New PathHunter® cell-based assays from DiscoveRx
Jan 12, 2016 ... PathHunter Interleukin assays measure receptor activation through receptor- receptor interactions at the surface of intact live cells. These ready-to ...
DiscoverX Solutions for Drug Discovery -
DiscoverX is the industry's leading provider of innovative cell-based assays and services for drug discovery and development.
DiscoveRx, Jubilant Biosys Announce Agreement for Screening ...
DiscoveRx's PathHunter ss-. Arrestin and HitHunter cAMP assays are homogeneous chemiluminescent assays which are rapidly becoming. GPCR screening ...
PathHunter™ eXpress β-Arrestin Assays - NET
DiscoveRx name and logo are a trademark of DiscoveRx Corporation. GraphPad Prism is a registered trademark of GraphPad Software, Inc. © 2009 DiscoveRx ...
How Similar Is Similar Enough?
Jan 30, 2015 ... Helen Roberts, Ph.D. Director DiscoveRx. Abhishek Saharia, Ph.D. Director DiscoveRx. New Tools Allow Comparison of Efficacy, Safety, and ...
serine/threonine kinase 11 | LKB subfamily | IUPHAR/BPS Guide to ...
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/ services/ ...
Accelerate Development Of Cancer Immunotherapy (iOnc) Drugs ...
Jan 12, 2016 ... DiscoveRx Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, announced ...
Eurofins DiscoverX Grants Bioassay Certification to VelaLabs
Feb 27, 2020 ... Eurofins DiscoverX partners with VelaLabs to enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP ...
Evotec Signs Agreement with DiscoveRx Corporation to Support ...
Oct 20, 2009 ... For our customers, this agreement means that DiscoveRx's innovative assay portfolio of more than. 300 cell based GPCR assays can be ...
Accelerating Biologic and Biosimilar Drug Development: Ready-to ...
Jan 13, 2016 ... Figure 1: DiscoveRx's proprietary PathHunter enzyme fragment complementation (EFC) technology consists of the β-galactosidase (β-gal) ...
Oncoceutics GPCR Discovery Partner DiscoverX Highlights ...
DiscoverX, a leader in GPCR profiling and screening services, recently highlighted imipridones, Oncoceutics' proprietary class of small molecules, discussing ...
PathHunter® Activated GPCR Internalization Assay
- http://www.cosmobio.co.jp/product/uploads/document/DRX_70-259-PathHunter-Activated-GPCR-Internalization-Cell-Line_REV5_1.pdf
The designated cells and reagents purchased from DiscoveRx are restricted in their use. DiscoveRx has developed an assay for translocation and ...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | Not Applicable | H2 Headings: | Not Applicable |
| H3 Headings: | 13 | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | 1 | Total Images: | 9 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-35011328-1 |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Contact Us | 3 | 1.014 % | No |
| CRO Certification | 3 | 1.014 % | No |
| Pathway Reporters | 2 | 0.676 % | No |
| Cells Cell | 2 | 0.676 % | No |
| Cell Lines | 2 | 0.676 % | No |
| Signaling Pathway | 2 | 0.676 % | No |
| Protein Degradation | 2 | 0.676 % | No |
| Assays Targeted | 2 | 0.676 % | No |
| Targeted Protein | 2 | 0.676 % | No |
| Lines Assay | 2 | 0.676 % | No |
| Degradation Signaling | 2 | 0.676 % | No |
| Ready Kits | 2 | 0.676 % | No |
| KnowledgeBased Videos | 2 | 0.676 % | No |
| Submit an | 2 | 0.676 % | No |
| an Order | 2 | 0.676 % | No |
| of Targets | 2 | 0.676 % | No |
| List of | 2 | 0.676 % | No |
| Target Engagement | 2 | 0.676 % | No |
| Membrane Preps | 2 | 0.676 % | No |
| Preps Proteins | 2 | 0.676 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Protein Degradation Signaling Pathway | 2 | 0.676 % | No |
| Targeted Protein Degradation Signaling | 2 | 0.676 % | No |
| Assays Targeted Protein Degradation | 2 | 0.676 % | No |
| Degradation Signaling Pathway Reporters | 2 | 0.676 % | No |
| Cells Cell Lines Assay | 2 | 0.676 % | No |
| Lines Assay Ready Kits | 2 | 0.676 % | No |
| Cell Lines Assay Ready | 2 | 0.676 % | No |
| Cell Banks for Bioassays | 2 | 0.676 % | No |
| AZ List of Targets | 2 | 0.676 % | No |
| – Discover Confidently New | 1 | 0.338 % | No |
| Hands – Discover Confidently | 1 | 0.338 % | No |
| Your Hands – Discover | 1 | 0.338 % | No |
| Discover Confidently New Products | 1 | 0.338 % | No |
| Confidently New Products Programs | 1 | 0.338 % | No |
| Products Programs COVID19 Assays | 1 | 0.338 % | No |
| New Products Programs COVID19 | 1 | 0.338 % | No |
| in Your Hands – | 1 | 0.338 % | No |
| Expertise in Your Hands | 1 | 0.338 % | No |
| Integrated Discovery prev next | 1 | 0.338 % | No |
| Services Integrated Discovery prev | 1 | 0.338 % | No |
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Sun, 04 Apr 2021 10:12:35 GMT
Content-Type: text/html; charset=utf-8
Content-Length: 10873
Connection: keep-alive
Cache-Control: no-cache, no-store, must-revalidate
Pragma: no-cache
Content-Encoding: deflate
Expires: -1
Vary: Accept-Encoding
Server: Microsoft-IIS/10.0
X-Frame-Options: SAMEORIGIN
X-UA-Compatible: IE=Edge
X-AspNet-Version: 4.0.30319
X-Powered-By: ASP.NET
Strict-Transport-Security: max-age=63072000
Domain Information
| Domain Registrar: |
Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
|
|---|---|
| Registration Date: | 1999-03-15 2 decades 5 years 8 months ago |
| Last Modified: | 2021-01-11 3 years 10 months 5 days ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns-1521.awsdns-62.org | |
205.251.197.241 | United States |
| ns-1686.awsdns-18.co.uk | |
205.251.198.150 | United States |
| ns-447.awsdns-55.com | |
205.251.193.191 | United States |
| ns-813.awsdns-37.net | |
205.251.195.45 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| discoverx.com | A | 293 |
IP: 54.71.10.74 |
| discoverx.com | A | 293 |
IP: 52.42.252.147 |
| discoverx.com | NS | 86400 |
Target: ns-1521.awsdns-62.org |
| discoverx.com | NS | 86400 |
Target: ns-1686.awsdns-18.co.uk |
| discoverx.com | NS | 86400 |
Target: ns-447.awsdns-55.com |
| discoverx.com | NS | 86400 |
Target: ns-813.awsdns-37.net |
| discoverx.com | SOA | 900 |
MNAME: ns-1686.awsdns-18.co.uk RNAME: awsdns-hostmaster.amazon.com Serial: 1 Refresh: 7200 Retry: 900 Expire: 1209600 |
| discoverx.com | MX | 3600 |
Priority: 20 Target: mx2-us1.ppe-hosted.com |
| discoverx.com | MX | 3600 |
Priority: 5 Target: cust5028-2.in.mailcontrol.com |
| discoverx.com | MX | 3600 |
Priority: 1 Target: cust5028-1.in.mailcontrol.com |
| discoverx.com | MX | 3600 |
Priority: 10 Target: mx1-us1.ppe-hosted.com |
| discoverx.com | TXT | 300 |
TXT: atlassian-domain-verification=k8Ue-T1Pdz FO5+xRKMeuNS5YBkvpf/n+g+NcbBx6QJ6Ec2kg1o 2FS6PtxMGWQ629 |
| discoverx.com | TXT | 300 |
TXT: v=spf1 include:_spf.act-on.net include:amazonses.com ~all |
| discoverx.com | AAAA | 293 |
IPV6: 2600:1f14:f7e:901:511f:d6c4:64e8:7c2d |
| discoverx.com | AAAA | 293 |
IPV6: 2600:1f14:f7e:900:27ea:b1f2:600d:c971 |
Full WHOIS Lookup
Registry Domain ID:
4340980_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.ascio.com
Registrar URL: http://www.ascio.com
Updated
Date: 2021-01-11T08:24:53Z
Creation Date:
1999-03-15T05:00:00Z
Registry Expiry Date:
2022-01-10T16:46:00Z
Registrar: Ascio Technologies, Inc. Danmark -
Filial af Ascio technologies, Inc. USA
Registrar IANA ID:
106
Registrar Abuse Contact Email: [email protected]
Registrar
Abuse Contact Phone: +1.4165350123
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
NS-1521.AWSDNS-62.ORG
Name Server:
NS-1686.AWSDNS-18.CO.UK
Name Server: NS-447.AWSDNS-55.COM
Name
Server: NS-813.AWSDNS-37.NET
DNSSEC: unsigned
URL of the ICANN
Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>>
Last update of whois database: 2021-04-04T10:12:32Z
Similarly Ranked Websites
U tri klika do zaposlenika! - Selekcija.hr
Brz i jednostavan applicant tracking system (ATS) sa svim vrstama video intervjua, psihološkim procjenama kandidata za posao, "procjenama 360 stupnjeva" i anketiranjima...
1,392,218 
$ 960.00
Home | CeCredential Trust, A Division of Paradigm, Inc.
CeCredential Trust is the market leader in the generation of secure, portable and verifiable electronic credentials.
1,392,249 $ 960.00